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Aims: To determine the factors that affect why some infants receive higher exposures relative to the
mother’s body burden than do others.
Methods: A total of 159 mother-infant pairs from a cohort of women receiving prenatal care at Magee-
Womens Hospital in Pittsburgh, PA from 1992 to 1995 provided blood samples at delivery for lead
determination. The difference between cord and maternal blood lead concentration (PbB) and a
dichotomous variable indicator of higher cord than maternal PbB, were examined as indicators of relative
transfer. Women were interviewed twice during the pregnancy about lifestyle, medical history, calcium
nutrition, and physical activity.
Results: Higher blood pressure was associated with relatively greater cord compared with maternal PbB,
as was maternal alcohol use. Sickle cell trait and higher haemoglobin were associated with a lower cord
relative to maternal blood lead PbB. No association was seen with smoking, physical exertion, or calcium
consumption.
Conclusion: While reduction in maternal exposure will reduce fetal exposure, it may also be possible to
mitigate infant lead exposure by reducing transfer from the pregnant woman. Interventions aimed at
reducing blood pressure and alcohol consumption during pregnancy may be useful in this regard.
E
xposure to lead causes developmental problems.
Although postnatal and childhood exposure can have
effects at low concentrations,1 children who have been
exposed to lead in utero may also suffer from deficits in
development (such as intelligence, information processing,
memory, and verbal skills),2–7 growth,8 9 and behaviour.10 11
Because lead is incorporated into the bone matrix where it is
retained for decades,12 13 prenatal exposure to lead also
contributes to an earlier and cumulatively greater body
burden.14 15
Maternal and infant blood lead levels (PbB) are highly
correlated across a wide range of exposure levels,16–18 so the
most obvious sources of variation in fetal lead dose are those
that affect the maternal PbB. Some sources of infant PbB
reflect direct maternal exposure, such as occupational lead
exposure, exposure to lead paint, or use of lead glazed
ceramics.19 Since cigarette smoke contains lead,20 21 smoking
and passive smoking could fall into this category as well.22
Other factors associated with infant PbB may reflect a
lifestyle associated with increased environmental exposure to
lead. Maternal coffee consumption and alcohol use,22 23
higher blood pressure,24 25 and seasonal patterns26–28 are such
variables.
For over 30 years, it has been recognised that lead freely
crosses the placenta via diffusion.29 30 It has generally been
assumed that there is no general enhancement or barrier to
transfer.31 However, factors besides the maternal lead
exposure and PbB also appear to affect the concentration in
fetal blood. Although maternal PbB is on average about 30%
higher than the infant’s, in most studies approximately one
quarter of the infants have PbB higher than their mothers.32–36
Rothenberg and coworkers reported that drinking milk
rarely, higher maternal age and parity, and caesarean section
delivery predicted increased cord lead after controlling for
maternal PbB.37 38 Sikorski et al found higher maternal-fetal
ratios in rural subjects, and a correlation between maternal:
fetal lead ratio and maternal:fetal iron and zinc ratios.39
Given inter-individual variability in maternal:cord PbB, we
hypothesised that there might be modifiable factors that
contribute to passage of lead to the fetus and that
identification of such factors could suggest ways to reduce
the burden of lead in newborns beyond what is achieved by
reducing maternal lead exposure. For this reason, we
examined variables that might influence the amount of lead




During 1992–95, women were recruited for a longitudinal
study of lead, calcium, and blood pressure during preg-
nancy.40 Women were eligible to participate if they were in
prenatal care before week 12, planned to deliver at Magee-
Womens Hospital, had single gestations, spoke English, were
over 18, were white or African-American, and did not have
chronic diseases. A total of 498 women were part of the initial
cohort; 24 delivered elsewhere and 44 miscarried. Whole
blood samples were collected from the women at up to five
points during pregnancy and at delivery. Because of budget
constraints, it was only possible to assay one sample per
trimester for some women: 345 had at least one lead
measurement taken, and of these, 229 had PbB determina-
tion on their blood sample collected at delivery. A total of 162
infants had cord blood lead determined, leading to 159 pairs
with lead measurements available for this analysis (fig 1).
Protocols used in this study were approved by the
Institutional Review Boards of Magee-Womens Hospital
and the University of North Carolina School of Public
Abbreviations: AAS, atomic absorption spectroscopy; ALA-D, d-
aminolevulinic acid dehydratase; BMI, body mass index; CLIA, Clinical
Laboratory Improvement Amendment of 1988; Hb, haemoglobin; PbB,
blood lead concentration; RBC, red blood cell
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Health. Written informed consent was obtained from all
subjects.
Lead determination
The protocol for blood drawing and lead measurement has
been previously described.40 The University of California San
Francisco–San Francisco General Hospital Metals Laboratory
analysed samples concurrently with the study data collection,
using electrothermal atomic absorption spectroscopy (AAS)
with continuum background correction. Interassay precision
had a coefficient of variation of 6% at 2 mg/dl. In 1998 the
Lead Poisoning/Trace Elements Laboratory at the New York
State Department of Health analysed blood samples that had
been frozen, using electrothermal atomisation AAS with
Zeeman background correction.41 This method is transferable
to a continuum based AAS instrumentation.42 Intermediate
precision estimates using New York State’s RM 028 (6.7 mg/
dl) are 0.2 mg/dl by the continuum correction method and
0.1 mg/dl by Zeeman corrected AAS.41 At a detection limit of
0.75 for Zeeman AAS and 0.50 for continuum AAS, the
precision is approximately 0.25 and 0.17 mg/dl, similar to that
reported at 6.7 mg/dl.
Several comparisons were made to determine the accept-
ability of values measured years after blood collection. First,
both laboratories participated satisfactorily in Clinical
Laboratory Improvement Amendment (CLIA) approved
proficiency testing programmes for blood lead using similar
analytical methodologies. Twenty specimens were analysed
by both laboratories, and of these, 80% were within 1 mg/dl,
with the remainder split between specimens that were higher
in the concurrent analysis and those higher in the later
determination. Second, we recently replicated our published
analyses40 of the maternal determinants of blood lead
concentration (PbB) and found that the regression models
showed the same variables to be predictive regardless of
whether the lead determinations were conducted concur-
rently or later. Third, the findings in the present examination
of cord versus maternal blood lead were unchanged by
inclusion or exclusion of the later assays. Therefore, we
included them in the analyses presented.
Of the 159 pairs with information on both maternal and
cord lead, 141 PbB determinations were completed concur-
rently with specimen collection (1992–95) and 18 in 1998. In
106 cases, the maternal blood draw was performed during
labour, and in 53 cases, after delivery. PbB was expressed in
mg of lead per dl of whole blood.
Data collection
Trained staff interviewed the women face-to-face twice
during their pregnancies, once shortly after enrolment (mean
week of gestation: 14, range 8–18), and once late in the
pregnancy (mean week: 36, range 31–41). Women were
questioned about their medical, occupational, and lifestyle
characteristics. Calcium intake was assessed through a
modified Block food frequency questionnaire,43 which
included the foods that account for most of the calcium
consumed in the typical US diet,44 as well as questions on
antacid, supplement, and vitamin use. Dietary calcium was
calculated using the Block DIETSYS software version 3.0,45
and the Physician’s Desk Reference provided estimates for
calcium from antacids and supplements.46 Blood pressure
was taken by study personnel according to the protocol of the
ARIC (Atherosclerosis Risk in Communities) study.47 Medical
records were abstracted for details of medications used;
prenatal, labour, and delivery histories; and information
about the infant.
Predictor variables
Certain factors were considered as possible sources of
variation in the difference between maternal and fetal PbB,
based on previous literature on humans and animals
(table 1). Since blood flow and blood pressure have been
linked to lead in humans and guinea pigs,48 we evaluated
systolic and diastolic blood pressure and self-reported
hypertension among the variables that we screened.
Because the blood-bone lead equilibrium changes during
Policy implications
N These findings give additional support to efforts to
control blood pressure (particularly in those over 30
years of age), encourage iron supplementation when
appropriate, and reduce alcohol consumption during
pregnancy.
N Interventions to reduce prenatal exposure to lead can
target not only overall maternal exposure, but also
modifiable factors that influence transfer from the
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Figure 1 Creation of a cohort among Pittsburgh, PA women seeking
prenatal care at Magee-Womens Hospital, 1992–95. PbB, blood lead.
Main messages
N Higher blood pressure in some groups and alcohol
consumption were associated with more lead in cord
blood relative to maternal blood lead.
N Higher haemoglobin and sickle cell trait were asso-
ciated with reduced lead in cord blood relative to
maternal blood lead.
N No associations were seen with calcium intake,
physical activity, or smoking.
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pregnancy, calcium (which may affect the release of lead
from bone40 49), haemoglobin (Hb), and sickle cell trait were
examined. Reproductive history, medication use, and infec-
tion could also have effects on the structure or blood flow of
the placenta.50 Because fetal stress has been associated with
increased relative lead burden,51 we looked at factors such as
birth weight and Apgar score. Finally, factors that might
reflect the measurement and sample properties were exam-
ined, such as delayed versus concurrent lead analysis and
time of maternal blood draw relative to delivery.
To represent variability in amount of lead transferred, the
difference between cord and maternal whole PbB concentra-
tion, as well as a dichotomous indicator of whether the cord
PbB was higher/not higher than maternal PbB, were the
outcomes for this study. The ratio of maternal to cord PbB
was also examined.
Statistical analysis
To determine comparability across three groups of subjects,
analysis of variance was performed. The three groups were:
those without a cord PbB, those for whom PbB was measured
a few years after data collection, and those with cord PbB
determination performed concurrently with data collection.
Initially, to reduce a large list of candidate predictors of
potential maternal-fetal transfer, bivariate associations were
examined for each variable and outcome; variables that were
significant at a=0.20 or OR greater than 2 were included in
subsequent linear and logistic models. All variables that
passed this initial bivariate screen were then included in
multiple linear (for the difference) and logistic (for the
dichotomous outcome) models, in which variables were
eliminated that satisfied a criterion of p . 0.20. In the next
step, some variables that were not predictive of the outcome
at a=0.20 were reintroduced to examine as potential
confounding: race, age, parity, and smoking. In most cases,
inclusion of these variables did not change the effect
estimates in the multivariable models, so they were not
included in the final model.52 Finally, variables that were
predictive of the cord-maternal PbB difference were entered
in the logistic model, and vice versa. Interactions with age
and weight gain were examined as well.
A number of sensitivity analyses were performed. Because
the samples analysed later may have been compromised, we
report models with and without those observations. The
extent of the effect of missing data was assessed using
multiple imputation with SAS’s PROC MI and PROC
MIANALYZE. Sickle cell trait, weight gain, and alcohol use
later in pregnancy were each missing for some observations,
and the imputation model contained those variables as well
as race, age, pre-pregnancy body mass index (BMI),
education, smoking status, alcohol use at other times, and
the other variables in the prediction model. As additional
sensitivity analyses, the models were fit using only the
measurements that could be considered to be more robust:
those maternal and cord samples with PbB above 1 mg/dl and
the maternal specimens collected before delivery.
RESULTS
Mean maternal PbB at delivery was 1.93 mg/dl, with a range
of 0.55–4.70 mg/dl; mean cord lead was 1.64 mg/dl, with a
range of 0.05–3.95 mg/dl. The Pearson correlation coefficient
between maternal and cord PbB was r=0.79. On average,
cord PbB was lower than maternal PbB by 0.30 mg/dl (95% CI
20.38 to 20.21 mg/dl), with a range of 21.93 to 1.20; 45 of
the pairs (28%) had the cord blood value higher than the
mother’s PbB.
The women included in this analysis differed in some ways
from those in the overall parent study: they were more likely
to be white, nulliparous, and higher income than those
lacking a cord measurement (table 2). Although the samples
analysed for lead at a later time point were chosen randomly,
the women differed in some respects from those for whom
PbB was measured concurrently with data collection: they
were more likely to be white and older, and their babies were
of lower birth weight.
Bivariate analysis indicated a number of factors associated
with maternal-fetal PbB difference (table 1), but in multi-
variate modelling, the strongest associations were seen with
medical factors (table 3). Maternal Hb and sickle cell trait
were associated with reduced fetal lead relative to maternal
lead. Compared with the 25th centile of maternal Hb, the
75th centile was associated with 1.32 mg/dl lower cord
relative to maternal blood lead. Children born to women
with sickle cell trait had on average 0.8 mg/dl relatively lower
lead. There was a significant interaction between age and
blood pressure as well as weight gain and blood pressure:
among mothers aged 30 years or over, or those who had
gained more weight during pregnancy, a higher blood
pressure was associated with a relatively greater lead
concentration in the cord blood. The findings were
unchanged when analysis was limited to the specimens
analysed concurrently with data collection (table 3).
Table 1 Factors found, in a bivariate screen, to be
associated with cord blood lead relative to maternal





Black race neg 0
Highest income category 0 neg
Separated marital status pos pos
Educational disadvantage 0 neg
Lifestyle
Alcohol pos pos
Coffee/tea drinks per month 0 neg
Passive smoking pos 0
Milk while adolescent neg 0
Medical/obstetric
5 minute Apgar score pos 0
Baby to intensive care unit neg 0
Number of abortions pos 0
Number of miscarriages neg 0
Chlamydia pos 0
Trichomonas neg 0
Sexually transmitted disease pos 0
Genitourinary infection neg neg
Cold medicines neg 0
Augmented labour neg neg
Systolic blood pressure pos pos
Diastolic blood pressure 0 pos
Weight gain pos 0
BMI 0 pos
Haemoglobin neg neg
Factors affecting blood lead measurement
Blood specimen measured later pos pos
*The following variables were not associated with either the difference or
the ratio: age; calcium consumed during the pregnancy; calcium intake
from milk; milk intake as a child; physical exertion at home or work;
infant weight, length, or head circumference; parity; use of nausea
medications; complications of labour and delivery; gestational age at
birth; paternal exposure to lead; time between blood draw and birth.
Variables associated with difference between maternal and cord PbB at
p = 0.20 or showing a difference .0.1. pos indicates association with a
higher lead level of cord blood, relative to maternal; neg indicates
association with lower lead level of cord blood; 0 indicates no
association.
`Variables associated with binary outcome at p = 0.20 or OR .2. pos
indicates increased odds of higher lead level of cord blood, relative to
maternal; neg indicates association with lower lead level of cord blood;
0 indicates no association.
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Similar factors were significant in the logistic model
(table 4), although all the women with sickle cell trait
(n=5) had maternal lead higher than their infant, so this
variable could not be included. The logistic model also
showed increased odds of the cord PbB being higher than the
maternal PbB for infants delivered by caesarean section. Both
the blood pressure and caesarean section associations were
attenuated when the samples analysed later were omitted.
A few non-medical variables were associated with the
outcome. Alcohol consumption in the second and third
trimesters was associated with an OR of 7.7 (95% CI 2.4 to
24.4) for higher cord than maternal PbB; no association was
seen for first trimester alcohol consumption. Children born in
the winter had relatively higher cord PbB than maternal
(season was not associated with the timing of lead
determination).
Calcium intake and physical exertion were not associated
with differences between maternal and cord PbB (table 1).
Those with greater fetal PbB relative to maternal PbB did not
differ with regard to race, parity, or smoking, nor did these
variables confound any of the results.
Use of the ratio of maternal/cord PbB as an outcome
measure yielded results similar to those of the difference
between maternal and cord PbB (data not shown). Data were
missing for 10 (6%) of the observations on at least one of the
following: sickle cell trait, weight gain, alcohol use. For
models of the cord-maternal difference in PbB, multiple
imputation gave essentially identical beta estimates as
models based on only the complete observations, except for
Hb, which increased from 21.18 to 21.04 mg/dl; standard
errors and p values were similarly close. Restriction of the
analysis to those measurements greater than 1 mg/dl changed
the beta estimates only in the second decimal place.
Restriction of the model to those samples taken before
delivery strengthened the sickle cell and delivery in winter
associations (for the difference, from 20.76 to 20.94 and
from 0.12 to 0.26, respectively; all other variables changed by
less than 0.06).
DISCUSSION
This analysis looked at factors that might influence the dose
of lead an infant receives, relative to maternal PbB. The
results suggest that alcohol use late in pregnancy, maternal
Hb during pregnancy, and blood pressure may explain some
of the variability in cord PbB beyond that explained by the
mother’s lead level.
Rothenberg’s group has studied the same issue in a more
highly lead exposed population than ours.37 38 They found a
decreased maternal/cord ratio associated with high blood
pressure, caesarean delivery, parity, and increasing maternal














blood (n = 67)
p*n (%) n (%) n (%)
Race
Black 64 (46) 6 (32) 38 (58)
White 74 (54) 13 (68) 27 (42) 0.08
Age (y)
18–20 42 (30) 3 (16) 9 (13)
21–25 53 (38) 9 (47) 32 (48)
26–30 30 (21) 1 (5) 13 (19)
.30 15 (11) 6 (32) 13 (19) 0.02
Parity
0 62 (44) 9 (47) 19 (28)
1 46 (33) 4 (21) 22 (33)
2+ 32 (23) 6 (32) 26 (39) 0.09
Annual income category`
,$10000 56 (46) 4 (24) 36 (59)
$10–$15000 25 (21) 3 (18) 5 (8.2)
$15–$25000 19 (16) 5 (29) 12 (20)
.$25000 21 (17) 5 (29) 8 (13) 0.08
Smoking, interview 1 or 2
Non-smoker 89 (64) 12 (63) 43 (64)
Smoker 51 (36) 7 (37) 24 (36) 1.00
Mean calcium intake
.1200 mg/day 87 (62) 12 (63) 42 (63)
,1200 mg/day 53 (38) 7 (37) 25 (37) 0.99
Treated for anaemia1
Yes 36 (26) 4 (22) 15 (23) 0.87
No 104 (74) 14 (78) 51 (77)
Mean maternal lead at
delivery (SD) 1.96 (0.84) 1.73 (0.97) 2.10 (0.98) 0.27
Mean cord blood lead (SD) 1.65 (0.76) 1.57 (0.79) 0.69
Mean birth weight in grams
(SD) 3309 (491) 2890 (373) 3165 (664) 0.00
Mean haemoglobin in
g/100 ml (SD) 12.1 (0.84) 12.2 (0.67) 12.0 (0.77) 0.69
Mean systolic blood
pressure throughout
pregnancy in mmHg (SD) 112 (7.6) 110 (5.9) 112 (7.1) 0.75
*Two sided, x2 test for categorical variables, ANOVA for continuous variables.
Four women missing or other race.
`Missing data on 27 women.
1Missing data on 2 women.
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age, and increased maternal/cord ratio with daily milk
drinking and previous premature birth (Rothenberg et al,
personal communication). We also found a relatively higher
fetal PbB with increased blood pressure (among women over
30 years and with increasing weight gain), even though
women with underlying hypertension were excluded from
our study. Although the mechanism for the effect of blood
pressure is not clear, lead has been associated with blood
pressure in adults in several studies.53 54 Unlike previous
studies, which have focused on lead as a predictor of
cardiovascular health outcomes, in this study we were
interested in the potential effects of blood pressure on lead
levels as the outcome. Our results differ from those of
Rothenberg et al with respect to caesarean section and parity.
We saw no association with calcium intake, unlike
Rothenberg and despite a previous article associating higher
maternal PbB with lower calcium.40 It is possible that the
effects of these factors are only apparent at high levels of
exposure, or the methods of analysis gave rise to divergent
findings (the structure of the statistical models is different).
One of the strongest associations in our data was with
alcohol consumption reported at the second (late pregnancy)
interview: higher alcohol use was associated with a greater
cord PbB relative to maternal PbB. Alcohol has been shown to
potentiate the effects of lead and to cause increased
absorption by various organs in rats.55 Our results are
consistent with the analyses of Ernhart and colleagues23
and Rabinowitz,22 but not with that of Rothenberg and
colleagues.38 We do not know if the levels of alcohol
consumption differed in the Mexico City women as compared
with our study cohort.
We also saw an association with Hb, which may change the
proportions of bound lead versus free plasma lead or correct
for haemodilution. Similarly, sickle cell trait appears to
reduce cord PbB, perhaps due to a different affinity for lead of
sickle red blood cells, as compared with normal red blood
cells (RBCs).56 57
Strengths of our study include detailed measurement of a
large number of covariates and prospective measurements.
Sensitivity analyses indicated the results were robust. For
instance, at low levels of lead small measurement errors
could have a large impact, but restriction of the model to only
those women with lead higher than 1 mg/dl did not change
the conclusions. Likewise, blood loss at delivery, fluid
replacement, and stress conditions could affect maternal
and fetal PbB concentrations, but restriction to the maternal
blood samples taken before delivery did not change the
overall conclusions. With regard to haemodilution, we
Table 3 Results of multiple linear regression models predicting the difference between cord and maternal blood lead in a
cohort of Pittsburgh, PA pregnant women, 1992–95
All samples (n = 159)
All samples analysed shortly
after delivery (n = 131)
b 95% CI b 95% CI
Sample analysed in second batch 0.20 20.03 to 0.44
Blood pressure, centred, per 10 mm Hg 20.06 20.20 to 0.08 Blood pressure, centred, per 10 mm Hg 20.06 20.20 to 0.08
Mean Hb, per 1 g/100 ml 20.12 20.22 to 20.02 Mean Hb, per 1 g/100 ml 20.12 20.22 to 20.02
Alcohol, 2nd interview, yes/no 0.36 0.14 to 0.58 Alcohol, 2nd interview, yes/no 0.33 0.10 to 0.55
Sickle cell trait 20.76 21.21 to 20.32 Sickle cell trait 20.74 21.17 to 20.30
Previous miscarriage 20.20 20.39 to 20.01 Previous miscarriage 20.23 20.43 to 20.03
Delivery in winter 0.12 20.05 to 0.29 Delivery in winter 0.10 20.08 to 20.28
Mother .30 y 20.22 20.44 to 0.00 Mother .30 y 20.08 20.32 to 0.16
Weight gain .40 lb 0.01 20.16 to 0.19 Weight gain .40 lb 0.02 20.17 to 0.20
Blood pressure 6mother’s age .30 0.36 0.09 to 0.62 Blood pressure 6mother’s age .30 0.35 0.07 to 0.64
Blood pressure 6weight gain 0.26 0.04 to 0.47 Blood pressure 6weight gain 0.28 0.05 to 0.50
Positive association indicates increased relative amount of lead transferred.
Table 4 Models of dichotomous (cord higher/not higher than maternal)
b 95% CI OR 95% CI
All samples (n = 157)
Sample analysed in second batch 1.63 0.35 to 2.91 5.11 1.42 to 18.33
Blood pressure, centred, per 10 mm Hg 0.40 20.19 to 0.99
Mean Hb, per g/100 ml 20.61 21.14 to 20.08 0.55 0.32 to 0.93
Alcohol, 2nd interview, yes/no 2.04 0.88 to 3.19 7.67 2.41 to 24.38
Caesarean section 21.25 23.04 to 0.55 0.29 0.05 to 1.73
Previous miscarriage 20.82 22.08 to 0.43 0.44 0.13 to 1.54
Previous abortion 0.78 20.21 to 1.77 2.18 0.81 to 5.89
Delivery in winter 0.79 20.10 to 1.69 2.21 0.91 to 5.40
Mother .30 y 22.09 24.10 to 20.08
Blood pressure 6mother’s age .30 4.02 0.75 to 7.29
All samples analysed shortly after delivery (n = 138)
Blood pressure, centred, per 10 mm Hg 0.43 20.17 to 1.03
Mean Hb, per g/100 ml 20.58 21.12 to 20.04 0.56 0.33 to 0.96
Alcohol, 2nd interview, yes/no 1.92 0.76 to 3.09 6.84 2.13 to 21.92
Caesarean section 20.88 22.69 to 0.93 0.42 0.07 to 2.54
Previous miscarriage 20.84 22.19 to 0.52 0.43 0.11 to 1.68
Previous abortion 0.62 20.43 to 1.67 1.85 0.65 to 5.29
Delivery in winter 0.66 20.30 to 1.61 1.93 0.74 to 5.01
Mother .30 y 21.17 23.19 to 0.85
Blood pressure 6mother’s age .30 2.66 20.12 to 5.43
Positive association increased odds of having cord PbB higher than maternal.
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controlled for Hb, and also note that adjustment for weight
gain as a continuous or categorical variable did not modify
the other results. Some data were missing, but imputation
showed they had little effect. The examination of a large
number of variables could have created spurious chance
associations, but the similarity of effects estimated in three
forms (linear difference, logistic, and exponential model of
the ratio [not shown]) as well as their confirmation in other
studies, argue that this is not the case. The lead measure-
ments were not all analysed at the same lab, and some
(40/451, 9%) of the stored samples that were not analysed
had small clots, leading us to suspect the validity of those
measurements. However, the effect estimates were not
confounded by timing or location of laboratory analysis.
Thus, the consistency of findings throughout these sensitivity
analyses strengthens confidence in the associations.
The study population was predominantly young, low
income, and urban, and was balanced between white and
African-American women; the exclusion of women who were
not in prenatal care by week 13 may limit generalisability.
Women who had both cord and maternal lead measurements
at delivery were different from other women in the broader
study; they were of lower parity, higher income, and their
babies were of higher birth weight. It is difficult to determine
whether these differences are important or not. Labour
progresses more rapidly for women of higher parity and
delivery is quicker for low birth weight infants, who also have
more complications. Therefore, lack of a cord blood sample
could simply be a marker for either a quick delivery or a
complicated birth, when the nurses might not have had time
to collect the specimen.
Lead transfer has a greater potential impact in more highly
exposed populations; our cohort had a low mean level, as is
currently common in the USA (mean lead for this study
<2 mg/dl, US mean for ages 20–49=2.1 mg/dl58). Despite the
low concentrations, known risk factors for increased lead
were easily identified, as we reported in previous work,40
indicating a high signal:noise ratio in the lead determina-
tions. The consistency for many of our findings with other
studies of more highly exposed populations provides reassur-
ance that the associations are not artefacts. Also, the
maternal-cord PbB association has been shown to be linear
across a wide range of levels.16
Future studies should seek more refined methods of
measuring placental transfer; differences between maternal
and cord PbB are only partial measures of transfer. Any factor
that caused changes in the maternal plasma-RBC-bone
equilibrium or in excretion, resorption, or accumulation of
lead in the fetus, or that affected placental transfer per se,
could alter the difference between maternal and cord PbB.
We had measurements in whole blood; plasma blood
lead may be more predictive of cord blood lead.59 The
d-aminolevulinic acid dehydratase (ALA-D) genotype may
influence lead susceptibility,60 and ALA-D activity is higher in
cord than maternal blood.61 Also, knowledge of both the total
Hb and the percentage of fetal versus adult Hb in the cord
blood would have been valuable, since fetal Hb has a higher
affinity for lead than does adult Hb62 and its proportion of the
total varies across newborns. Notably, sudden infant death
syndrome has been linked both to lead,63 as well as the
percent adult haemoglobin in the newborn.64
In conclusion, this analysis suggests that sickle cell trait,
alcohol use, and maternal blood pressure and haemoglobin,
among other factors, influence lead transfer to the fetus. If
corroborated, these findings could give additional impetus to
efforts to control blood pressure (particularly in those over 30
years of age), encourage iron supplementation when appro-
priate, and reduce alcohol consumption during pregnancy.
While the best way to reduce prenatal transmission is to
reduce maternal exposure to lead, future research should also
focus on how we can mitigate lead’s effects on development
by reducing transfer to the infant.
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